Apimeds Pharmaceuticals US, Inc. SEC filings APUS
Apimeds Pharmaceuticals US, Inc. has 130 filings in SEC EDGAR's recent list, going back to Jan 29, 2024. Its latest annual report, Form 10-K, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Nov 5, 2026 | Oct 1, 2026 |
| 3 | Initial insider ownership | Nov 2, 2026 | Dec 1, 2025 |
| 3 | Initial insider ownership | Nov 2, 2026 | Dec 1, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 7, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 30, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 26, 2026 | — |
| 4/A | Primary document | Nov 21, 2025 | May 12, 2024 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4/A | Primary document | Jun 11, 2025 | May 12, 2025 |
| 3/A | Primary document | Jun 11, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | May 19, 2025 | — |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 3/A | Primary document | May 14, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | May 8, 2025 | Mar 4, 2025 |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APUS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Matawan, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1894525
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.